US Lawsuits Allege GLP-1 Weight-Loss Drugs Caused Vision Loss

Hundreds of patients in the US have sued makers of GLP-1 diabetes and weight-loss drugs, alleging the medicines caused vision loss from a rare eye condition called NAION. The lawsuits, filed in a Pennsylvania federal court, claim drugmakers failed to adequately warn patients. Companies deny the allegations. The cases have raised safety questions in India, where GLP-1 use is growing.